Intelligence Feed event · Equity · 2026-10-13

    Abbott Sets Q3 2026 Earnings Release for October 21 with $12.91B Revenue Forecast

    Question

    Abbott Sets Q3 2026 Earnings Release for October 21 with $12.91B Revenue Forecast

    Direct answer

    Abbott Laboratories gained 2.23% to close at $101.82 ahead of its scheduled Q3 earnings release on October 21, 2026. The stock outperformed the broader market as healthcare positioning shifted toward large-cap medtech names. Consensus estimates forecast quarterly earnings of $1.42 per share on revenue of $12.91 billion, representing year-over-year increases of 9.23% and 13.52% respectively, supported by stable global diagnostics and medical device demand.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-13
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Abbott Sets Q3 2026 Earnings Release for October 21 with $12.91B Revenue Forecast”, revision 1, evidence through 2026-10-13. https://marketontology.com/market-events/2026-10-13/abbott-sets-q3-2026-earnings-release-for-october-21-with-12-91b-revenue-forecast-3ca7f3

    EQUITY
    Abbott Sets Q3 2026 Earnings Release for October 21 with $12.91B Revenue Forecast
    Abbott Laboratories gained 2.23% to close at $101.82 ahead of its scheduled Q3 earnings release on October 21, 2026. The stock outperformed the broader market as healthcare positioning shifted toward large-cap medtech names. Consensus estimates forecast quarterly earnings of $1.42 per share on revenue of $12.91 billion, representing year-over-year increases of 9.23% and 13.52% respectively, supported by stable global diagnostics and medical device demand.
    ABT
    Impact
    63
    OCT 13
    SIG
    88%
    ABT
    Abbott Sets Q3 2026 Earnings Release for October 21 with $12.91B Revenue Forecast
    Abbott Laboratories gained 2.23% to close at $101.82 ahead of its scheduled Q3 earnings release on October 21, 2026. The stock outperformed the broader market as healthcare positioning shifted toward large-cap medtech names. Consensus estimates forecast quarterly earnings of $1.42 per share on revenue of $12.91 billion, representing year-over-year increases of 9.23% and 13.52% respectively, supported by stable global diagnostics and medical device demand.
    → Sustained medical device procedure volume and diagnostics demand drive 13.52% revenue expansion, expanding ABT operating margins.
    Impact
    Abbott Laboratories gained 2.23% to close at $101.82 ahead of its scheduled Q3 earnings release on October 21, 2026. The stock outperformed the broader market as healthcare positioning shifted toward large-cap medtech names. Consensus estimates forecast quarterly earnings of $1.42 per share on revenue of $12.91 billion, representing year-over-year increases of 9.23% and 13.52% respectively, supported by stable global diagnostics and medical device demand.
    Affected
    ABT
    Transmission
    Sustained medical device procedure volume and diagnostics demand drive 13.52% revenue expansion, expanding ABT operating margins.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    ABTmedtech revenue growth supporting forward operating margin expansionUp1-4wQ3 earnings expected Oct 21 with consensus EPS $1.42 (+9.23% YoY) and revenue $12.91B (+13.52% YoY).

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month